Deep Vein Thrombosis. Acute embolism and thrombosis of deep veins of lower extremity
Conditions
Interventions
Intervention 1: Intervention group: patients with a tibial fracture will consume 80 mg Aspirin tablets produced by "Pars Daroo" every 12 hours for 35 days to prevent deep vein thrombosis. Intervention
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
14 Years to 85 Years
Inclusion criteria
Inclusion criteria: Male and Females between 14 and 85 years old Tibial fractures with or without surgery indication
Exclusion criteria
Exclusion criteria: Hip or femur fracture Major fracture except tibia DVT or PTE history Low platelet levels (lower than 100,000) Gustilo type 3B and higher open fractures Patients that have contraindication to use Aspirin or Heparin Patients that avoid to participate in the study Patients with chronic kidney disease that have lower GFR than 30
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of deep vein thrombosis in lower extremity. Timepoint: At the end of first week, fourth week, 12th week, and 24th week after discharge. Method of measurement: Physical examinations an doppler ultra sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Peptic ulcer disease. Timepoint: At the end of first week, fourth week, 12th week, and 24th week after discharge. Method of measurement: Short questionnaire with 10 questions. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Sheikhy
Tehran University of Medical Sciences
Outcome results
None listed